Weiguo Xiang

1.5k total citations · 1 hit paper
16 papers, 846 citations indexed

About

Weiguo Xiang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Weiguo Xiang has authored 16 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Organic Chemistry. Recurrent topics in Weiguo Xiang's work include Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (5 papers) and Peptidase Inhibition and Analysis (3 papers). Weiguo Xiang is often cited by papers focused on Protein Degradation and Inhibitors (6 papers), Ubiquitin and proteasome pathways (5 papers) and Peptidase Inhibition and Analysis (3 papers). Weiguo Xiang collaborates with scholars based in United States, China and Sweden. Weiguo Xiang's co-authors include Chao‐Yie Yang, Shaomeng Wang, Lijie Zhao, Xin Han, Chong Qin, Tianfeng Xu, Krishnapriya Chinnaswamy, Jeanne A. Stuckey, Mi Wang and Longchuan Bai and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Materials Processing Technology and Bioorganic & Medicinal Chemistry.

In The Last Decade

Weiguo Xiang

14 papers receiving 835 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer

2019 303 citations Xin Han, Chao Wang et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Weiguo Xiang United States	7	743	336	235	141	40	16	846
Arnold Bolomsky Austria	12	450 0.6×	200 0.6×	312 1.3×	23 0.2×	21 0.5×	31	603
Rikio Suzuki Japan	12	495 0.7×	172 0.5×	253 1.1×	35 0.2×	24 0.6×	30	666
P. Buhl-Jensen United Kingdom	10	467 0.6×	202 0.6×	59 0.3×	32 0.2×	14 0.3×	13	564
Sinto Sebastian United States	8	265 0.4×	188 0.6×	76 0.3×	50 0.4×	15 0.4×	11	412
Heung Kyoung Lee South Korea	13	235 0.3×	178 0.5×	56 0.2×	82 0.6×	49 1.2×	18	391
Sourik S. Ganguly United States	10	244 0.3×	142 0.4×	75 0.3×	74 0.5×	25 0.6×	15	403
Yu-Gang Song China	4	440 0.6×	200 0.6×	101 0.4×	20 0.1×	28 0.7×	10	519
Sho Kubota Japan	16	369 0.5×	122 0.4×	97 0.4×	30 0.2×	28 0.7×	46	552
Teresa Hernández‐Iglesias Spain	8	313 0.4×	147 0.4×	179 0.8×	41 0.3×	39 1.0×	11	487
David Remillard United States	10	725 1.0×	184 0.5×	147 0.6×	68 0.5×	43 1.1×	11	797

Countries citing papers authored by Weiguo Xiang

Since Specialization

Citations

This map shows the geographic impact of Weiguo Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiguo Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiguo Xiang more than expected).

Fields of papers citing papers by Weiguo Xiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiguo Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiguo Xiang. The network helps show where Weiguo Xiang may publish in the future.

Co-authorship network of co-authors of Weiguo Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Weiguo Xiang. A scholar is included among the top collaborators of Weiguo Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiguo Xiang. Weiguo Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yang, Donghua, et al.. (2025). Achieving excellent mechanical properties of FSW steel/Al joints via the addition of a novel Al-Si-Cu-Ni-La filler metal. Journal of Materials Processing Technology. 344. 119019–119019.

Kuo, Calvin, Weiguo Xiang, Diane E. Merry, et al.. (2025). PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models. Neurotherapeutics. 22(6). e00732–e00732.

Xiang, Weiguo & Shaomeng Wang. (2022). Therapeutic Strategies to Target the Androgen Receptor. Journal of Medicinal Chemistry. 65(13). 8772–8797. 30 indexed citations

Dang, Ying, Xiaoling Zhang, Ping Kang, et al.. (2021). [Evaluation of Air Pollution Characteristics and Air Quality Improvement Effect in Beijing and Chengdu].. PubMed. 42(8). 3622–3632. 2 indexed citations

Han, Xin, Lijie Zhao, Weiguo Xiang, et al.. (2021). Strategies toward Discovery of Potent and Orally Bioavailable Proteolysis Targeting Chimera Degraders of Androgen Receptor for the Treatment of Prostate Cancer. Journal of Medicinal Chemistry. 64(17). 12831–12854. 104 indexed citations

Xiang, Weiguo, Lijie Zhao, Xin Han, et al.. (2021). Discovery of ARD-2585 as an Exceptionally Potent and Orally Active PROTAC Degrader of Androgen Receptor for the Treatment of Advanced Prostate Cancer. Journal of Medicinal Chemistry. 64(18). 13487–13509. 110 indexed citations

Xiang, Weiguo, et al.. (2020). The 3-D conformational shape of N-naphthyl-cyclopenta[d]pyrimidines affects their potency as microtubule targeting agents and their antitumor activity. Bioorganic & Medicinal Chemistry. 29. 115887–115887. 6 indexed citations

Xiang, Weiguo & Shaomeng Wang. (2020). Selectively Targeting Tropomyosin Receptor Kinase A (TRKA) via PROTACs. Journal of Medicinal Chemistry. 63(23). 14560–14561. 6 indexed citations

Xiang, Weiguo, et al.. (2019). Discovery of amide-bridged pyrrolo[2,3-d]pyrimidines as tumor targeted classical antifolates with selective uptake by folate receptor α and inhibition of de novo purine nucleotide biosynthesis. Bioorganic & Medicinal Chemistry. 27(23). 115125–115125. 1 indexed citations

10.

Han, Xin, Chao Wang, Chong Qin, et al.. (2019). Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer. Journal of Medicinal Chemistry. 62(2). 941–964. 303 indexed citations breakdown →

11.

Xiang, Weiguo, Fuzhang Wang, & Xian Zhang. (2019). Research on Integration of Multi-source BIM Models Based on GIS Platform. 4. 40–44. 3 indexed citations

12.

Han, Xin, Lijie Zhao, Weiguo Xiang, et al.. (2019). Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands. Journal of Medicinal Chemistry. 62(24). 11218–11231. 159 indexed citations

13.

Xiang, Weiguo, Chao‐Yie Yang, & Longchuan Bai. (2018). MCL-1 inhibition in cancer treatment. OncoTargets and Therapy. Volume 11. 7301–7314. 109 indexed citations

14.

Xiang, Weiguo, Shruti Choudhary, Ernest Hamel, Susan L. Mooberry, & Aleem Gangjee. (2018). Structure based drug design and in vitro metabolism study: Discovery of N-(4-methylthiophenyl)-N,2-dimethyl-cyclopenta[d]pyrimidine as a potent microtubule targeting agent. Bioorganic & Medicinal Chemistry. 26(9). 2437–2451. 8 indexed citations

15.

Ou, Tinghai, Yanxiang Liu, Deliang Chen, et al.. (2011). The influence of large-scale circulation on the summer hydrological cycle in the Haihe River basin of China. Acta Meteorologica Sinica. 25(4). 517–526. 2 indexed citations

16.

Xiang, Weiguo, et al.. (2010). The coronary anomaly: right coronary artery originates from the mid left anterior descending artery.. PubMed. 22(9). E166–7. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact